Navigation Links
Pharmaxis Reports Phase II Results for Aridol in COPD
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pharmaxis Reports Phase Results for Aridol COPD
(Date:8/18/2008)...t 18 /- Oramed,Pharmaceutic... ), a developer,of oral delivery systems, announce...udy to Assess the Safety, Pharmacokinetics (PK) an...lations in Healthy,Subjects," has been chosen for ...f the European Association for the Study of Diabet...
(Date:8/18/2008)...- Micromet, Inc.,(Nasdaq: ...el, proprietary,antibodies for the treatment of ca...ost a webcast and conference call this morning, Mo...(4:00 p.m. Central European,Time) to discuss the b...l,SCIENCE on August 15, 2008., To access the webc...
(Date:8/14/2008)...ry Continuing Education Activity, VOORHEES, N.J.,...a,significant cause of morbidity and mortality in ...ion. The clinical manifestations of CMV disease ar...to life-threatening,pneumonia, myelosuppression, r...CMV infection and reduce CMV drug resistance, it i...
(Date:8/14/2008)...logy Evaluated to Enable Targeting and Increase ...g, LEXINGTON, Mass. and HEIDELBERG, Germany, Aug....nomics Research Institute (TGen) today announced,t... evaluate,Next-Generation-Sequencing equipment in ...roarray Technology., febit,s HybSelect(TM) Techno...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 1Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 2Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 3Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 4China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 1China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 2China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 3China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 4China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 5China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 6Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday March 17 3413 1Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday March 17 3413 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 1Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3B Provides 2008 Outlook 3412 18
... 2007 /PRNewswire-FirstCall/,- OncoGenex Technolog...unced that preliminary data from ongoing clinical ...an Society of Clinical,Oncology Annual Meeting (AS...II clinical study of OGX-011 in hormone refractory...al study of,OGX-011 in non-small cell lung cancer....
... in Lipoprotein Lipase,Deficiency Established , Am...m Molecular,Therapeutics (AMT), a leader in the fi... I/II clinical trial results with its lead,product...Lipoprotein Lipase (LPL) deficient patients at the...ne Therapy (ASGT) in Seattle.,The study,s lead inv...
Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ne 26 issue of Archives of Internal Medicine, whic...t women who have severe hot flashes// may have mor...he article explains that almost 85% of women in me...ened sensations to heat that may also mean increas...
...ssor has set aside all the popular opinion by sayi...althy--than wine, bringing cheers// to all the bee...science department at the University of California...d professor, told food scientists assembled here T...
...ave signed three agreements on renewal of cooperat...th and environmental and occupational health for a...g (MoUs) to renew the agreements, first initialled...ral discussions between India's Health and Family ...
...atients with community-acquired pneumonia (CAP), l... infection, can reduce the length of antibiotic //...which is the first research trial of its kind, app...of the American Journal of Respiratory and Critica...
Other Medicine News:Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Beer is More Healthier Than Wine 2Health News:Biomarker Reduces Length of Antibiotic Treatment 2Health News:Biomarker Reduces Length of Antibiotic Treatment 3
The QIAamp Viral RNA Mini Kit allows purification of viral nucleic acids from cell-free fluid samples. Examples of viral nucleic acids that can be isolated with this kit include, but are not limited
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe
MAP D-Type can combine a number of assay steps for up to 180 microplates on a simple to use benchtop device. The D-Type base instrument is a multifunctional stand-alone device but also provides easy
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi
Medicine Products: